Furthermore, Jianpi Huayu Formula downregulates Piezo1 expression and inhibits the PI3K/AKT/mTOR pathway, sensitizing HCC to doxorubicin (Fang et al., 2025). This evidence concerns the gene AKT1 and hepatocellular carcinoma.